EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Continuing automated insulin delivery systems during hospitalisation with type 1 diabetes: A thematic literature review

Hannah Cunningham iD, Alicia Jenkins, David N O'Neal iD, Melissa H Lee

Diabetic Medicine · 01.07.2026

DOI: 10.1111/dme.70372 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diabetic Medicine, online erschienen am 01.07.2026. Verfasst von Hannah Cunningham und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

A thematic review that identifies and summarises available evidence for people with Type 1 diabetes (T1D) continuing automated insulin delivery (AID) systems in the hospital setting, primarily with a focus on assessing the in‐hospital safety and efficacy of AID use.

Methods

A thematic review was conducted searching Embase, MEDLINE and EBSCO for English language publications from 2014 to 2025 using keywords including AID system brands and terms related to insulin pumps and to inpatients. Eligible studies included original research, retrospective observational studies and case reports and series.

Results

Of 1043 articles identified, 1037 did not meet the inclusion criteria. Six articles were reviewed in detail, and a further two papers were identified by screening the reference list of the six papers. There is a paucity of evidence, with heterogeneous methodology regarding the safety and efficacy of continuing AID in hospitalised people with T1D. Results support the feasibility of continuing AID use from the ambulatory to the inpatient setting in hospitalised people with T1D. There is a trend towards improved time in recommended glucose ranges or mean glucose levels without increased hypoglycaemia. There were no adverse glucose outcomes or diabetic ketoacidosis reported.

Conclusions

Whilst continuing AID in the inpatient setting appears promising, our review identified significant heterogeneity in patient populations, device types, as well as limited data on healthcare professional perspectives and person‐reported outcomes. Further studies and guidelines are merited. Until then, inpatient use of AID should be guided by specialist diabetes healthcare teams with expertise in diabetes technology.

Schlagwörter

Stichwörter der Autor:innen

Continuous Glucose MonitoringHospitalisationInpatientsInsulin Infusion PumpsPatient SafetyType 1 Diabetes Mellitus

Autor:innen und Institutionen

  • Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.
  • Department of Endocrinology, St Vincent's Hospital, Melbourne, Victoria, Australia.
  • Australian Centre for Accelerating Diabetes Care, University of Melbourne, Melbourne, Victoria, Australia.
  • Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
  • Department of Endocrinology, Werribee Mercy Hospital, Werribee, Victoria, Australia.

ORCID-Profile: Hannah Cunningham, David N O'Neal

Zitieren

APA

Cunningham, H., Jenkins, A., O'Neal, D. N., & Lee, M. H. (2026). Continuing automated insulin delivery systems during hospitalisation with type 1 diabetes: A thematic literature review. Diabetic Medicine. https://doi.org/10.1111/dme.70372

Vancouver

Cunningham H, Jenkins A, O'Neal DN, Lee MH. Continuing automated insulin delivery systems during hospitalisation with type 1 diabetes: A thematic literature review. Diabetic Medicine. 2026. doi:10.1111/dme.70372

BibTeX
@article{Cunningham2026,
  author = {Cunningham, Hannah and Jenkins, Alicia and O'Neal, David N and Lee, Melissa H},
  title = {Continuing automated insulin delivery systems during hospitalisation with type 1 diabetes: A thematic literature review},
  journal = {Diabetic Medicine},
  year = {2026},
  doi = {10.1111/dme.70372}
}
Kostenlos starten →